-
Ferring Pharmaceuticals and North Zealand University Hospital announce eHealth collaboration aimed at transforming IBD patient care
-To mark World IBD Day 2016, Ferring Pharmaceuticals and North Zealand University Hospital in Copenhagen…
-
Ferring Pharmaceuticals announces approval for NOCDURNA®, a new therapeutic option for the treatment of adults waking multiple times to urinate at night
-Ferring Pharmaceuticals today announced that NOCDURNA® (desmopressin) has received approval in the EU…
-
Newly created Swiss Polar Institute to launch a major Antarctic expedition
-The future of the Earth’s poles is critical. In the coming decades, major international negotiations will focus on the polar regions, which are bearing…
-
Wake up to nocturia: The most common cause of disrupted sleep that could be damaging your health
-Today is ‘World Sleep Day’ which was initiated by the World Association of Sleep Medicine (WASM) to acknowledge the importance of a…
-
Ferring Pharmaceuticals opens Asia Pacific headquarters in Singapore
-The new Ferring Asia-Pacific Regional Headquarters focuses on supply chain planning and coordination to support the growth of emerging markets…
-
Healthcare Supply Chain Academy (HSCA) program launched by International Institute for the Management of Logistics (IML) in collaboration with Ferring Pharmaceuticals, Merck and Supply Chain Operations SA
-In collaboration with Ferring Pharmaceuticals, Merck and Supply Chain Operations SA…
-
Ferring announces the start of the PRONOUNCE Trial for patients with advanced prostate cancer and cardiovascular disease receiving degarelix or leuprolide
-Ferring Pharmaceuticals announced today the commencement of the Phase 3b PRONOUNCE Trial. The trial will compare the occurrence of major…
-
Ferring Pharmaceuticals and Karolinska Institutet sign collaboration agreement on the development of a Human Microbiome Translational Research Programme
-Ferring Pharmaceuticals and Karolinska Institutet announce today that a collaboration agreement has been signed for the establishment of a…
-
Targeted Immuno Therapies AB and Ferring Pharmaceuticals sign a strategic collaboration agreement for the treatment of IBD
-Targeted Immuno Therapies (TLA) announced today that it has signed a strategic collaboration agreement with Ferring Pharmaceuticals…
PRESS RELEASE 2016
PRESS RELEASE 2016